Market Introduction
The platelet rich plasma therapy involves the use of local injections of the patient’s own concentrated platelets that helps to accelerate the healing of muscles, ligaments, tendons, and joints. The platelet rich plasma (PRP) has the potential to regenerate the tissues, thereby decreasing pain through the effect of bioactive molecules and growth factors that are present in alpha granules. The success of PRP therapy depends on the method of preparation, composition of PRP, medical condition of patients, and type of tissue wherein PRP is injected.
Market Overview and Dynamics
The India platelet rich plasma for chronic pain management market is expected to reach US$ 5,932.43 thousand by 2027 from US$ 2,437.50 thousand in 2019; it is anticipated to grow at a CAGR of 12.1% from 2020 to 2027. Factors driving the market growth include rise in number of musculoskeletal diseases andincrease in geriatric population. Whereas, the market is likely to have negative impact due to alternatives for chronic pain management coupled with poor doctor to patient ratio.
Key Market Segments
By indication, the arthritis segment held the largest share of the market in 2019. Moreover, the same segment is estimated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
A few of the major primary and secondary sources referred to while preparing the report on the India platelet rich plasma for chronic pain management market are Indian Orthopedic Association, Indian Council of Medical Research, and Organization for Economic Co-operation and Development.
Reasons to Buy report
India Platelet Rich Plasma for Chronic Pain Management Market
By Indication
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 2,437.50 thousand |
| Market Size by 2027 | US$ 5,932.43 thousand |
| CAGR (2020 - 2027) | 12.1% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Indication
|
| Regions and Countries Covered |
India
|
| Market leaders and key company profiles |
|
The India Platelet Rich Plasma for Chronic Pain Management Market is valued at US$ 2,437.50 thousand in 2019, it is projected to reach US$ 5,932.43 thousand by 2027.
As per our report India Platelet Rich Plasma for Chronic Pain Management Market, the market size is valued at US$ 2,437.50 thousand in 2019, projecting it to reach US$ 5,932.43 thousand by 2027. This translates to a CAGR of approximately 12.1% during the forecast period.
The India Platelet Rich Plasma for Chronic Pain Management Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the India Platelet Rich Plasma for Chronic Pain Management Market report:
The India Platelet Rich Plasma for Chronic Pain Management Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The India Platelet Rich Plasma for Chronic Pain Management Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the India Platelet Rich Plasma for Chronic Pain Management Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For India Platelet Rich Plasma for Chronic Pain Management Market
